Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid

OBJECTIVES: To develop a robust phenotypic antimicrobial susceptibility testing (AST) method with a correctly set breakpoint for pretomanid (Pa), the most recently approved anti-tuberculosis drug. METHODS: The Becton Dickinson Mycobacterial Growth Indicator Tube™ (MGIT) system was used at six labora...

Descripción completa

Detalles Bibliográficos
Autores principales: Bateson, Anna, Ortiz Canseco, Julio, McHugh, Timothy D., Witney, Adam A., Feuerriegel, Silke, Merker, Matthias, Kohl, Thomas A., Utpatel, Christian, Niemann, Stefan, Andres, Sönke, Kranzer, Katharina, Maurer, Florian P, Ghodousi, Arash, Borroni, Emanuele, Cirillo, Daniela Maria, Wijkander, Maria, Toro, Juan C., Groenheit, Ramona, Werngren, Jim, Machado, Diana, Viveiros, Miguel, Warren, Robin M., Sirgel, Frederick, Dippenaar, Anzaan, Köser, Claudio U., Sun, Eugene, Timm, Juliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155602/
https://www.ncbi.nlm.nih.gov/pubmed/35260883
http://dx.doi.org/10.1093/jac/dkac070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155602/
https://www.ncbi.nlm.nih.gov/pubmed/35260883
http://dx.doi.org/10.1093/jac/dkac070

Ejemplares similares